Free tool
FAERS Monitor: Seroquel
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020639 or its brand name (Seroquel, Quetiapine Fumarate). Reports on generic versions are filed under their own applications.
Reports
157,490
Serious
125,741
80% of reports
Hospitalization
58,685
Death reported
22,048
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective9,492
- off label use9,102
- toxicity to various agents8,281
- diabetes mellitus7,992
- insomnia7,269
- somnolence6,823
- drug interaction6,691
- fatigue6,643
- nausea6,296
- anxiety6,218
- weight increased6,164
- depression5,996
- completed suicide5,756
- dizziness5,428
- fall5,378
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,549 |
| 2005 | 1,921 |
| 2006 | 3,134 |
| 2007 | 5,526 |
| 2008 | 3,245 |
| 2009 | 7,250 |
| 2010 | 7,817 |
| 2011 | 8,248 |
| 2012 | 8,422 |
| 2013 | 4,100 |
| 2014 | 5,067 |
| 2015 | 6,662 |
| 2016 | 6,646 |
| 2017 | 8,242 |
| 2018 | 9,649 |
| 2019 | 9,933 |
| 2020 | 10,079 |
| 2021 | 9,051 |
| 2022 | 8,575 |
| 2023 | 8,805 |
| 2024 | 8,863 |
| 2025 | 8,363 |
| 2026 | 6,339 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,896,669 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| diabetes mellitusSignal | 7,992 | 15.5 | 15.2 | 97,547 |
| completed suicideSignal | 5,756 | 9.8 | 9.6 | 42,689 |
| toxicity to various agentsSignal | 8,281 | 6.8 | 6.7 | 39,614 |
| drug interactionSignal | 6,691 | 5.8 | 5.7 | 25,877 |
| somnolenceSignal | 6,823 | 4.6 | 4.5 | 19,059 |
| weight increasedSignal | 6,164 | 3.8 | 3.7 | 12,226 |
| insomniaSignal | 7,269 | 3.7 | 3.6 | 14,233 |
| depressionSignal | 5,996 | 3.6 | 3.5 | 11,012 |
| anxietySignal | 6,218 | 3.0 | 2.9 | 8,004 |
| fallSignal | 5,378 | 2.2 | 2.1 | 3,420 |
| dizziness | 5,428 | 1.5 | 1.4 | 792 |
| off label use | 9,102 | 1.4 | 1.4 | 1,038 |
| fatigue | 6,643 | 1.1 | 1.1 | 119 |
| nausea | 6,296 | 1.1 | 1.0 | 24 |
| drug ineffective | 9,492 | 1.0 | 0.9 | 15 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.